Clinical trials
Phase 2/3 Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2018 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Completed | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Monash University | 5 |
| AbbVie | 2 |
| ASLAN Pharmaceuticals | 1 |
| Amgen | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Hoffmann-La Roche | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 13 |
| Leukemia | 6 |
| Infections | 5 |
| Lymphoma | 5 |
| Neoplasms, Plasma Cell | 5 |
| Agammaglobulinemia | 1 |
| Anorexia | 1 |
| Bile Duct Neoplasms | 1 |
| Biliary Tract Neoplasms | 1 |
| Cachexia | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.